Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04724720 · ClinicalTrials.gov registry record · Phase 2

Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19

A Phase 2 study of COVID-19, sponsored by Northwell Health.

Active
Registry status
Phase 2
Development phase
56
Enrollment target
1
Study location

NCT04724720 is a Phase 2 study of COVID-19 that is active but no longer recruiting, run by Northwell Health. The registered enrollment target is 56 participants, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04724720, a Phase 2 study of COVID-19, is active but no longer recruiting, sponsored by Northwell Health.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this study is to evaluate the clinical efficacy of oral famotidine in symptomatic non-hospitalized patients with confirmed COVID-19. This study is expected to enroll up to 84 patients with mild to moderate symptoms divided into each of the two study arms. Clinical outcomes of the two treatment arms will be compared. This study will be conducted virtually/remotely.

Conditions Studied

COVID-19

Interventions

  • DRUG Placebo
  • DRUG Famotidine

Study Locations (1)

New York

  • Northwell Health - Lake Success

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2021-01-19
Est. Completion 2022-06
Phase Phase 2

Sponsor

Northwell Health

370 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04724720

The ClinicalTrials.gov registry entry for NCT04724720 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT04724720 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04724720 about?

NCT04724720 is a clinical study titled "Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19". The overall objective of this study is to evaluate the clinical efficacy of oral famotidine in symptomatic non-hospitalized patients with confirmed COVID-19. This study is expected to enroll up to 84 patients with mild to moderate symptoms divided into each of the two study arms. Clinical outcomes o...

What is the current status of trial NCT04724720?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 56 participants. The study started on 2021-01-19. Estimated completion is 2022-06.

What conditions does trial NCT04724720 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT04724720?

The interventions under investigation include: Placebo (DRUG), Famotidine (DRUG).

Who is sponsoring clinical trial NCT04724720?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04724720 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

COVID-19

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.